• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
/
Back to catalog
Home / Products / Pentoxifylline

Pentoxifylline

100 mg № 10, № 50
Pharmacotherapeutic group
Agents affecting cardio-vascular system
Active ingredient
Pentoxifylline
Pharmaceutical form
Enterosoluble tablets
ATC code
C04AD03
RX/OTC
RX
Registration certificate
UA/7189/01/01

General properties

Pharmacotherapeutic group

Peripheral vasodilators. Pentoxifylline.

Therapeutic indications

 

  • Atherosclerotic encephalopathy;
  • ischemic cerebral stroke, dyscirculatory encephalopathy;
  • violation of peripheral circulation due to atherosclerosis, diabetes mellitus (inclusive with diabetic angiopathy), inflammation;
  • trophic disorders in tissues associated with veins or microcirculatory disorders (postthrombophlebitic syndrome, trophic ulcers, gangrene, frostbite);
  • obliterating endarteritis;
  • angioneuropathy (Raynaud's disease);
  • violation of the circulation of the eye (acute, subacute, chronic circulatory failure in the retina and choroid of the eye);
  • disturbance of the inner ear function of vascular genesis, which is accompanied by a decrease in hearing.
Contraindications

Pentoxifylline is contraindicated: patients with hypersensitivity to pentoxifylline, to other methylxanthines or to any of the excipients of the drug; patients with massive bleeding (risk of increased bleeding); patients with extensive bleeding in the retina of the eye, with hemorrhages in the brain (risk of increased bleeding). If during the treatment with pentoxifylline there is a bleeding in the retina of the eye, the use of the drug should be stopped immediately; patients in the acute period of myocardial infarction; patients with a stomach ulcer and / or intestinal ulcers; patients with hemorrhagic diathesis.

Pharmaceutical characteristics

Main physicochemical properties

The tablets are round, covered with a shell, pink in color, the upper and lower surfaces of which are convex. On the fracture, when viewed under a magnifying glass, one can see a nucleus surrounded by a single continuous layer.

Shelf life
3 years.
Storage

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of the reach of children.

Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
Back to catalog
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
    • Partners
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2023. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • FP «LEKHIM» LLC
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту